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Abstract: Neural stem/progenitor cell (NS/PC)-based therapies
have shown exciting potential for regeneration of the central
nervous system (CNS) and NS/PC cultures represent an impor-
tant resource for disease modeling and drug screening. How-
ever, signiﬁcant challenges limiting clinical translation remain,
such as generating large numbers of cells required for model
cultures or transplantation, maintaining physiologically repre-
sentative phenotypes ex vivo and directing NS/PC differentia-
tion into speciﬁc fates. Here, we report that culture of human
NS/PCs in 3D, hyaluronic acid (HA)-rich biomaterial microenvi-
ronments increased differentiation toward oligodendrocytes
and neurons over 2D cultures on laminin-coated glass. More-
over, NS/PCs in 3D culture exhibited a signiﬁcant reduction in
differentiation into reactive astrocytes. Many NS/PC-derived
neurons in 3D, HA-based hydrogels expressed synaptophysin,
indicating synapse formation, and displayed electrophysiologi-
cal characteristics of immature neurons. While inclusion of
integrin-binding, RGD peptides into hydrogels resulted in a
modest increase in numbers of viable NS/PCs, no combination
of laminin-derived, adhesive peptides affected differentiation
outcomes. Notably, 3D cultures of differentiating NS/PCs were
maintained for at least 70 days in medium with minimal
growth factor supplementation. In sum, results demonstrate
the use of 3D, HA-based biomaterials for long-term expansion
and differentiation of NS/PCs toward oligodendroglial and neu-
ronal fates, while inhibiting astroglial fates. © 2019 Wiley Periodi-
cals, Inc. J Biomed Mater Res Part A: 107A: 704–718, 2019.
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INTRODUCTION
Although the central nervous system (CNS) has some innate
ability to regenerate, this ability is insufﬁcient to restore tis-
sue function in people afﬂicted by injury or neurodegenera-
tive conditions. In adults, limited regeneration is achieved by
an endogenous pool of neural stem/progenitor cells
(NS/PCs), which are actively recruited to damaged tissue
where they have the capacity to become new neurons and
glia.1–3 Glia cells include oligodendrocytes and astrocytes
and have distinct roles to support neuronal function. Oligo-
dendrocytes form an insulating myelin sheath around neuro-
nal axons to enable faster signal transmission and long-
range conduction. Astrocytes have a variety of functions,
including formation and maintenance of neuronal synapses
and the blood–brain barrier. However, many NS/PCs present
in damaged CNS tissue differentiate into reactive astrocytes,
which create a glial scar and, when in excess, likely contrib-
ute to a chronic inﬂammatory environment thought to pre-
vent regeneration.4–10
Over the past two decades, many studies have evaluated
the therapeutic potential of transplanting human NS/PCs or
oligodendrocyte progenitor cells (OPCs), the intermediary
progenitors between NS/PCs and mature oligodendrocytes
(Fig. 1), to regenerate CNS tissues after injury.8,11–18 While
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NS/PCs can become neurons, astrocyte or oligodendrocytes,
OPCs are restricted to the oligodendrocyte lineage. Differen-
tiation of transplanted NS/PCs toward oligodendrocytes has
led to signiﬁcant gains in functional recovery in rodent
models of spinal cord injury.8,11–18 Furthermore, transplan-
tation of OPCs has shown some promise for spinal cord
injury repair in recent clinical trials.17 Despite these positive
results, differentiation of NS/PCs into OPCs is inefﬁcient. The
best in vitro yields of human OPCs remain below 30%12,19–21
and in vivo below 25% of NS/PCs become oligodendrocytes
after transplantation into the injured rodent spinal
cord.16,22,23 While relatively few transplanted cells differenti-
ate and engraft into the host tissue, these few are able to
induce some functional improvement.14,17,24,25
The potential of stem cell-based therapies to improve
clinical outcomes after brain or spinal cord injury motivates
development of more effective strategies to direct
oligodendrocyte-lineage differentiation. Key factors in the
tissue microenvironment include the extracellular matrix
(ECM) and cell-secreted soluble factors.26 Compared to neu-
ron or astrocyte differentiation, oligodendrocyte differentia-
tion of human NS/PCs has been more difﬁcult to achieve.21
The majority of protocols previously described for differenti-
ation of NS/PCs toward oligodendrocytes rely on temporal
application of formulations of soluble bioactive factors, a
potent method of controlling differentiation.20,21,27 However,
as interactions between cells and the ECM are critical for oli-
godendrocyte differentiation,28,29 this study aimed to evalu-
ate whether provision of a deﬁned, synthetic ECM could
improve differentiation efﬁciency.
Biomaterials make excellent platforms for 3D cell culture
that can provide ECM-mimetic cues in a highly modiﬁable,
deﬁned manner.30 Biomaterial properties have been used to
direct cell fate31–33 through modulation of stiffness,34 swell-
ing ratio,35 geometry,36 and chemistry.37 Hydrogel biomate-
rials are often used because of their similarities to native
tissues, including high water content. They can be fabricated
from biocompatible and biodegradable polymers and their
mechanical properties tuned to span those found in native
brain and spinal cord.38 Hydrogel scaffolds have the poten-
tial to enable large-scale production of therapeutic cells by
providing control over their expansion and subsequent dif-
ferentiation into deﬁned phenotypes ex vivo prior to clinical
transplantation.
Hydrogels were fabricated based on hyaluronic acid
(HA), a nonsulfated glycosaminoglycan that is abundant in
CNS tissue and particularly enriched during embryonic
development and in adult NS/PC niches.39 HA regulates pro-
liferation and differentiation of Sox2+ NS/PCs through the
CD44 receptor.40,41 In inﬂammatory environments, high
molecular weight HA acts as a scavenger of damaging free
radical species.42 HA hydrogels can be modiﬁed to provide
additional matrix-derived functionalities, such as integrin-
binding and mechanical cues, in combination.43–45 Use of
aqueous, cytocompatible crosslinking chemistries enables 3D
encapsulation of live cells within hydrogels.46,47 HA hydro-
gels can be formulated with mechanical properties approxi-
mating native CNS tissues and are degraded by cell-
produced hyaluronidases.39 To enable cell adhesion,
integrin-binding peptides derived from ECM proteins can be
included.31,39,43,47–51 Implantation of HA hydrogels into the
brain or spinal cord after injury can reduce the local inﬂam-
matory response and glial scar deposition.30,52 Furthermore,
previous reports found that in vitro culture or ex vivo trans-
plantation of NS/PCs within HA hydrogels with mechanical
moduli mimicking healthy brain selectively increased differ-
entiation of NS/PCs toward neurons or oligodendrocytes
while decreasing astrocyte differentiation into reactive
astrocytes.53–58
In the present studies, we evaluated the effects of combi-
natorial presentation of laminin-derived adhesion peptides
on survival, proliferation and differentiation of human
NS/PCs in 3D culture. Laminins are key mediators of NS/PC
progression to mature, myelinating oligodendrocytes.59 For
FIGURE 1. Culture conditions and timeline. A timeline of media conditions is depicted above. The media composition is detailed in the inset table,
while the expected observation timelines for markers of NS/PC, OPC, pre-oligodendrocyte, mature oligodendrocyte, astrocyte, and neuron are
included below the media timeline. Differentiation marker timelines are from Miron et al.132
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example, when OPCs contact the laminin-rich ECM surround-
ing axons, engagement of integrin α6β1 switches OPCs to a
non-proliferative phenotype and initiates maturation.60 Sev-
eral regions of laminin I have been identiﬁed as mediators of
cell adhesion, including RGD, YIGSR, and IKVAV amino acid
sequences. RGD is a common integrin-binding site across
several ECM proteins. YIGSR and IKVAV support neuron
attachment, survival and neurite outgrowth in a synergistic
manner.61,62 Inclusion of peptides from these regions, rather
than whole laminin protein, in biomaterial scaffolds
increases local density of the bioactive sequence, and possi-
bly biological potency.63 As scaffolds are constructed from
the “bottom-up”, adding individual bioactive regions of ECM
proteins one at a time, they provide the opportunity to iso-
late the independent and combined effects of speciﬁc
peptide-integrin interactions. Decoupling the effects of differ-
ent ECM cues will enable creation of tailored, deﬁned matrix
environments containing the minimal elements necessary to
efﬁciently direct cell fate.
Here, we characterized effects of ECM-mimetic features
included in HA-based hydrogels on differentiation of 3D-
cultured NS/PCs, with the ultimate goal of identifying
matrix properties that can enrich differentiation toward
oligodendrocytes that can support CNS repair. HA content
and hydrogel modulus were chosen to best mimic proper-
ties of native CNS tissues. RGD, IKVAV and YIGSR peptides
were included alone and in combination and their effects
on viability and differentiation of NS/PCs were evaluated
over 70 days in culture. Cultures in media formulated to
maintain NS/PC “stemness” and to provide minimally nec-
essary support for oligodendrocyte differentiation were
compared. Finally, we characterized the electrophysiologi-
cal behavior of the differentiated neuronal cells in
hydrogels.
MATERIALS AND METHODS
All reagents were purchased from Thermo Fisher Scientiﬁc,
unless otherwise stated.
Hyaluronic acid preparation and hydrogel formation
Hydrogels were formed by Michael-type addition between
4-arm polyethylene glycol-maleimide (PEG-Mal, 20 kDa, Laysan
Bio) and thiolated HA (700 kDa HA, Lifecore Biomedical).64 In
brief, carbodiimide chemistry (N-hydroxysuccinimide, NHS;
1-ethyl-3-(3-dimethylaminopropyl), EDC) was used to add a
thiol from cystamine (Sigma-Aldrich) to the carboxylate group
on the glucuronic acid moieties of HA, creating thiolated HA
(HA-SH). Disulﬁde bridges were broken with dithiothreitol and
newly synthesized HA-SH puriﬁed via dialysis (12–14 kDa
molecular weight cut-off cellulose membrane, Spectrum Labs)
in deionized water, adjusted to pH 4 with hydrochloric acid
and changed at least twice daily for 3 days. Puriﬁed HA-SH
was sterile-ﬁltered and lyophilized for 2 days. A range of 4–6%
thiolation, deﬁned as thiol groups per HA disaccharide, was
used as determined with Ellman’s reagent (5,50-dithiobis-
(2-nitrobenzoic acid), Sigma-Aldrich).65,66
NS/PC culture
Neuralized H9 human embryonic stem cells (H9 hESCs) (Life
Technologies) were expanded, and stored in liquid nitrogen
vapors until use. NS/PCs were cultured in StemPro® hESC
serum-free media (Life Technologies) made with Dulbecco’s
Modiﬁed Eagle Medium: Nutrient Mixture F-12 (DMEM/F12)
containing 1× StemPro® neural supplement, 2 mM
Glutamax™, 0.1× antibiotic/antimycotic, 20 ng/mL basic
ﬁbroblast growth factor (bFGF), and 20 ng/mL epidermal
growth factor (EGF). Here, we will refer to this as “stem cell
maintenance” medium. NS/PCs were cultured in a humidi-
ﬁed 37C incubator with 5% carbon dioxide. Half of the
medium in each culture well was changed every 2 days.
After 4 weeks in culture, NS/PCs were transitioned to pre-
differentiation medium for 2 weeks, followed by an
oligodendrocyte-promoting differentiation medium for
4 weeks. Compositions of pre-differentiation and differentia-
tion media were adapted from Hu et al.67 A timeline of the
culture conditions is shown in Figure 1. Both pre-
differentiation and differentiation media used the stem cell
maintenance medium base without bFGF or EGF. Pre-
differentiation medium was supplemented with 10 ng/mL
platelet-derived growth factor AA (Peprotech) and 1 μM pur-
morphamine (Sigma-Aldrich), a sonic hedgehog agonist to
direct NS/PCs toward OPCs. Differentiation medium was
supplemented with 1 μM adenosine 30,50-cyclic monopho-
sphate (cAMP; Sigma-Aldrich) and 60 ng/mL triiodothyro-
nine (T3; Sigma-Aldrich) to direct OPCs toward
oligodendrocytes. Minimal growth factor supplementation
was used for these studies to obtain information about how
insoluble cues provided by 3D culture matrices affected
differentiation.
Prior to seeding 2D cultures for assessments of viability
and mRNA expression, tissue culture-treated polystyrene
wells were coated with CELLstart™ (Life Technologies)
diluted in phosphate buffered saline (PBS) in a humidiﬁed,
37C incubator for at least 2 h. After aspirating the
CELLstart™ solution, 25,000 NS/PCs per cm2 were seeded.
TrypLE™ Express (Life Technologies) was used to dissociate
adherent NS/PCs during passaging. For immunostaining
experiments, cells were seeded onto laminin-coated, 12 mm-
diameter glass coverslips. Prior to coating, glass coverslips
were cleaned by submerging in sulfuric acid for 20 min to
remove residues, rinsed three times with distilled, deionized
water (ddH2O), and autoclaved. Coverslips were ﬁrst coated
with a 50 μg/mL solution of poly-D-lysine (Sigma-Aldrich) in
sterile ddH2O in a humidiﬁed, 37C incubator for 1 h, rinsed
three times with sterile PBS (without calcium or magne-
sium), and then incubated with 10 μg/mL mouse laminin I
in sterile ddH2O for 2 h in a humidiﬁed, 37C incubator. Cov-
erslips were rinsed a ﬁnal three times in PBS before seeding
with 25,000 NS/PCs per cm2.
Prior to gelation and NS/PC encapsulation, PEG-Mal was
dissolved in PBS and sterile-ﬁltered. Peptides (Genescript,
Supplementary Table 1) containing thiols (i.e., cysteines)
near the N-termini were conjugated via Michael-type addi-
tion to an average of one arm of PEG-Mal prior to hydrogel
formation for a total peptide concentration of 270 μM in the
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ﬁnal hydrogels.64,68 PEG-Mal/peptide solutions were
adjusted to 10 mg/mL with PBS and kept on ice. HA-SH was
dissolved in DMEM/F12 (15 mg/mL). Once dissolved, the
HA-SH solution was adjusted to approximately pH 6 with
sterile 0.1 M NaOH. Next, 2.5 million NS/PCs per mL of HA-
SH (around 25,000 NS/PCs per a 20 μL hydrogel) were
added. The HA-SH solution with suspended NS/PCs was
adjusted to 10 mg/mL with DMEM/F12 and kept on ice. To
form cell-laden hydrogels, HA-SH with NS/PCs and PEG-
Mal/peptide solutions (10 μL of each) were mixed in sterile,
press-to-seal silicone isolators (12 × 4.5 mm diameter by
2 mm deep, Grace BioLabs) adhered to the bottom of a poly-
styrene Petri dish. Hydrogels became solid rapidly (within
30 s). Hydrogel cultures were placed in a humidiﬁed 37C
incubator for 15 min to complete gelation before they were
removed from the molds, and transferred to 48-well tissue
culture plates (400 μL media per well, 1 hydrogel culture
per well).
Rheology
Hydrogel samples were tested for rheological stiffness using
a Discovery Hybrid Rheometer (DHR2) from TA Instruments.
Samples were formulated as described in the previous sec-
tion, but with a ﬁnal volume of 150 μL in 8 × 9 mm diameter
by 2 mm deep, press-to-seal silicone isolators (Grace Bio-
Labs). After gelation, hydrogels were allowed to equilibrate
in PBS overnight at 4C. The next morning, hydrogels were
brought to room temperature and mounted onto the rheom-
eter for testing. A 9 mm, parallel-plate geometry was used to
perform an oscillation-frequency sweep with a 1% strain
logarithmic sweep at a frequency range of 0.1–10 Hz. The
storage and loss moduli were recorded and used to deter-
mine the complex modulus. Rheological properties of hydro-
gel are reported as average  standard deviation of
15 independent experiments, each with at least three techni-
cal replicates.
Immunocytoﬂuorescence
Neural stem/progenitor cells grown on 2D laminin-coated,
coverslips or in 3D hydrogels were ﬁxed by removing half of
their medium and replacing it with fresh, 4% paraformalde-
hyde in PBS. After 20 min, the ﬁxative was removed and cov-
erslips rinsed three consecutive times in PBS. Fixed
coverslips were stored at 4C in PBS until use. Fixed hydro-
gel cultures were then transitioned in to a solution contain-
ing 20% sucrose in Optimal Cutting Temperature compound
(OCT, Tissue-Tek) for sectioning samples using the following
successive steps: 5% sucrose in PBS (1 h), 20% sucrose in
PBS (2 × 30 min), 20% sucrose in PBS (overnight), 20%
sucrose in OCT (2 h), 20% sucrose in OCT. In the ﬁnal
sucrose OCT solution, samples were frozen in a slurry of dry
ice and 2-methylbutane, embedded in plastic molds, and
cryo-sectioned (18 μm thick sections).
Sections were permeabilized with 0.1% Triton-X 100 and
blocked using 4% normal donkey serum (Sigma-Aldrich)
with 2% bovine serum albumin in PBS with 0.05% Tween-
20. Triton-X 100 and Tween-20 were not used with
antibodies labeling cell surface antigens. Samples were
incubated with primary antibodies (Supplementary Table 2)
overnight, rinsed three times in PBS, and incubated for 2 h
with dye-conjugated, secondary antibodies raised in donkey
(1:500; Life Technologies) and Hoechst 33342 (1:1000;
ThermoFisher) to visualize nuclei. Samples were rinsed
three times in PBS and mounted with Fluoromount-G®
(SouthernBiotech). Wideﬁeld ﬂuorescence images were
acquired using an Axio Observer Z1 (Zeiss), Zen software
(Zeiss), and an ORCA-Flash4.0V.2 CMOS (Hamamatsu). Con-
focal ﬂuorescence images were acquired using a Leica TCS-
SP5. Maximum projections of confocal image stacks were
produced using Leica Application Suite X software.
mRNA expression
Prior to lysis, cells were isolated from hydrogels by incubat-
ing in a 1 mg/mL hyaluronidase (Sigma-Aldrich) solution in
0.01 M citrate buffer (pH 5.5) for 20 min at 37C in a humid-
iﬁed incubator and then rinsed once in PBS. mRNA was
isolated from lysed samples using the RNeasy and Qiash-
dredder kits (Qiagen) following instructions provided by the
manufacturer. Real-time PCR (RT-PCR) was performed using
a PCR master mix from Qiagen and an iQ5 qPCR machine
(Bio-Rad). All primer/probe mixtures were purchased from
Applied Biosystems (Supplementary Table 3). Samples were
diluted to equivalent RNA concentrations before running RT-
PCR and were normalized to GAPDH mRNA expression levels
from NS/PCs at day 0.
Viability measurement
Cell viability was measured with CellTiter-Glo® 3D Cell Via-
bility Assay (Promega) to quantify ATP present. Medium was
removed from hydrogels, which were then homogenized in
CellTiter-Glo® reagent and incubated for 30 min at room
temperature. Hydrogel viability was determined by measur-
ing luminescence on a plate reader (BioRad Synergy II) and
comparing raw values to luminescence of a standard curve
constructed from known numbers of NS/PC measured at the
same time.
Electrophysiology
Electrophysiology was performed at room temperature with
an Olympus BX51W1 upright microscope with optics for dif-
ferential interference contrast. All recordings were per-
formed at room temperature in an electrophysiology
microscope chamber containing regular artiﬁcial cerebral
spinal ﬂuid (ACSF) composed of 130 mM NaCl, 26 mM
NaHCO3, 10 mM glucose, 3 mM KCl, 2 mM MgCl2, 2 mM
CaCl2, and 1.25 mM NaH2PO4. Samples are oxygenated with
95% O2 and 5% CO2, maintained with a pH between 7.2 and
7.4 and osmolality between 290 and 310 mOsm/L. Whole-
cell patch clamp recordings in current-clamp mode were
performed using a MultiClamp 700B ampliﬁer (Molecular
Devices) and pCLAMP 10.3 acquisition software. The patch
pipette (3–5 MΩ resistance) contained a solution comprised
of 112.5 mM potassium-gluconate, 17.5 mM KCl, 10 mM
HEPES buffer, 5 mM ATP potassium salt, 5 mM ethylene
glycol-bis(β-aminoethyl ether)-N,N,N0,N0-tetraacetic acid
(EGTA), 4 mM NaCl, 1 mM MgCl2, 1 mM NaGTP, 0.5 mM
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CaCl2, and pH 7.2 with 270–280 mOsm/L. Capacitance, input
resistance, decay time constant and resting membrane
potential were recorded while holding the membrane poten-
tial at −70 mV and electrode access resistances were main-
tained at <30 MΩ.
Statistics
Statistical signiﬁcance for viability differences between pep-
tide groups was determined by evaluation with a Student’s
t-test and a Holm–Šidák method for multiple comparison
correction. A p < 0.05 was considered statistically signiﬁcant
after Holm–Šidák’s correction. Standard deviations for gene
expression data were determined by propagating error from
threshold cycle measurement for gene of interest and control
gene (GAPDH) as well as control RNA (NS/PCs from day 0)
following guidelines from Applied Biosystems.69 A two-way
ANOVA was performed on gene expression levels and statis-
tically signiﬁcant differences in means were determined with
a Hochberg method for multiple comparison correction
(Supplementary Table 4). The false-discovery rate was set to
0.05. A p < 0.05 was considered statistically signiﬁcant after
Hochberg’s correction.
RESULTS
Mechanical properties
The average complex shear modulus of HA hydrogels was
found to be 188  42 Pa with a range of 134–282 Pa, which
is consistent with native CNS tissue.55,70,71 Hydrogel storage
modulus was not signiﬁcantly affected by the addition of up
to 500 μM peptide (Supplementary Fig. 1).
Cell viability and proliferation
There were no signiﬁcant differences among groups day
7 after encapsulation (Supplementary Fig. 2). At day 28, more
viable cells were detected in all conditions. Multivariable
ANOVA (peptide condition, time) indicated signiﬁcant differ-
ences in cell viability (assessed by ATP content) at days
28 and 70 for all conditions (p < 0.02), but not day 42, for
both the stem cell maintenance and pre-oligodendrocyte
medium conditions (Fig. 2A). Within these timepoints, a
Holm–Šidák comparison test was used to evaluate statistical
signiﬁcance between peptide groups. At day 28, viability of
NS/PCs cultured in hydrogels with RGD in maintenance
medium was signiﬁcantly higher than in hydrogels with YIGSR
(p < 0.05) or CYS (p < 0.005). This difference may be
FIGURE 2. Viability in NS/PCs in 3D hydrogels. (A) The number of viable cells was quantiﬁed in each hydrogel condition using CellTiter-Glo®. Statis-
tically signiﬁcant differences were found between hydrogels with and without RGD at day 28 in STEM is represented with (*) and day 70 in DIFF is
represented by (#). Statistical signiﬁcance was evaluated using Student’s t-test with a Holm–Šidák sequential correction for multiple comparisons.
Error bars represent standard deviation (N ≥ 4). (B, C) Immunoﬂuorescence imaging was used to visualize apoptotic (B, cPARP, red) and proliferat-
ing (C, Ki67, green) cells, along with nuclear staining (B and C, Hoechst, blue), in 2D and 3D hydrogels with YIGSR, IKVAV, and RGD peptides at day
28 in culture. Images are magniﬁed 200×; inset images are magniﬁed 1000×. Media conditions were also varied: stem cell maintenance (STEM),
oligodendrocyte-lineage conditioning (PRE-DIFF), and oligodendrocyte differentiation (DIFF).
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attributed to some combination of improved cell survival and
higher levels of proliferation being present in the RGD condi-
tions. No signiﬁcant differences in NS/PC viability among
hydrogels with RGD, IKVAV, YIGSR+IKVAV, or YIGSR+IKVAV
+RGD were observed. At day 70 of culture in differentiation
medium, NS/PCs in hydrogels containing RGD (i.e., RGD or
YIGSR+IKVAV+RGD) had signiﬁcantly more viable cells than
those in hydrogels without RGD (i.e., YIGSR, IKVAV, YIGSR
+IKVAV, or CYS) (p < 0.05). For all peptide conditions, NS/PCs
cultured in pre-differentiation or differentiation medium had
decreased ATP activity compared to those in stem cell mainte-
nance medium.
Immunoﬂuorescent images of cleaved poly (ADP-ribose)
polymerase (cPARP) and Ki67 were used to indicate NS/PC
apoptosis and proliferation, respectively (Fig. 2B). There
were no observable differences in numbers of cPARP+ cells
among any conditions. However, there was a clear, qualita-
tive decrease in the numbers of proliferative cells (i.e., Ki67+
nuclei) when cultured in differentiation medium (days
42 and 70), compared to stem cell maintenance medium
(day 28), in agreement with results from ATP assays
(Fig. 2A). Cells in stem cell maintenance medium continued
to proliferate throughout their culture period. By day
42, these cultures became overconﬂuent within scaffolds.
Thus, cultures in stem cell maintenance medium were dis-
continued at day 42. As cells cultured in differentiation
medium had slowed proliferation, they were continued to
day 70.
Stem cell maintenance. Effects of peptides on NS/PC fate
were assessed based on mRNA (RT-PCR) and protein (immu-
nostaining) expression of lineage-speciﬁc markers. SOX2, a
transcription factor indicative of multipotent NS/PCs, was
not signiﬁcantly altered by 3D culture as measured by mRNA
(Fig. 3A). Protein levels of SOX2 and nestin, another com-
monly used marker for NS/PCs,72 were evaluated using
FIGURE 3. Maintenance of “stemness” in cultured NS/PCs. (A) Levels of SOX2 mRNA were evaluated using RT-PCR in 2D and 3D cultures under
varying media conditions: stem cell maintenance (STEM), oligodendrocyte-lineage conditioning (PRE-DIFF), and oligodendrocyte differentiation
(DIFF). Error bars show the standard deviation (N ≥ 4). (B) NS/PCs cultured in 2D (top) or 3D with YIGSR, IKVAV, and RGD peptides (bottom) were
immunoﬂuorescently labeled for nestin (red) and SOX2 (green). Cells cultured in STEM (42 days, left) or in differentiation conditions (PREDIFF, days
28–42 + DIFF, days 43–70; right) both showed expression of nestin and SOX2. Images are 200×; inset images are 1000×.
FIGURE 4. CD44 expression by NS/PCs decreases when cultured in 3D, HA-based hydrogels. (A) CD44 mRNA was evaluated with RT-PCR in 2D and
3D cultures with varying peptides under varying media conditions: stem cell maintenance (STEM), oligodendrocyte-lineage conditioning (PRE-DIFF),
and oligodendrocyte differentiation (DIFF). All 3D culture conditions showed statistically signiﬁcant decreases in CD44 expression for day 28 STEM
and day 42 PREDIFF compared to 2D controls (*). Error bars show the standard deviation (N ≥ 4). (B) Cells cultured in either 2D (top) or 3D with
YIGSR, IKVAV, and RGD peptides (bottom) were immunoﬂuorescently labeled for CD44. NS/PCs showed very little discernable CD44 expression in
all conditions Images are 200×; inset images are 1000×.
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immunoﬂuorescence (Fig. 3B). Qualitatively, expression of
SOX2, in particular nuclear SOX2, and nestin protein
appeared to decrease after culture in differentiation medium.
Together, results suggest that only a few NS/PCs maintain
stemness throughout the 70-day culture period.
Levels of CD44, a marker of NS/PCs and receptor for HA,
were evaluated. Compared to 2D culture, NS/PCs in 3D cul-
ture HA hydrogels displayed a trend toward reduced levels
of cd44 mRNA in all peptide and media conditions at all time
points (Fig. 4A). However, this difference was only statisti-
cally signiﬁcant at day 28 in stem cell maintenance medium
and day 42 in pre-differentiation medium (for all peptide
conditions). Immunoﬂuorescent labeling in 3D HA hydrogels
indicated sporadic CD44 expression in few cells (Fig. 4B).
Oligodendrocyte-lineage differentiation. In all 3D cultures
independently of peptide or media conditions, mRNA levels of
olig2, a transcription factor present in CNS glial and motor
neuron progenitors,73,74 signiﬁcantly increased (Fig. 5A).75
Furthermore, increased levels of OLIG2 protein was observed
in 3D hydrogel cultures in all media conditions (Fig. 5B). Qual-
itatively, more NS/PCs appeared positive for nuclear OLIG2
protein after culture in differentiation medium in both 2D and
in 3D conditions. This shift from cytoplasmic to nuclear locali-
zation of OLIG2 protein indicates functional differentiation
away from glial ﬁbrillary acidic protein (GFAP)-positive astro-
cytes and toward progenitors of either oligodendrocytes,
motor neurons, or ﬁbrous astrocytes.58,76–78 Oligodendrocyte-
lineage differentiation was characterized at days 42 (stem cell
maintenance medium) and 70 (differentiation medium) using
immunoﬂuorescence staining for platelet-derived growth
factor-α (PDGFR-α, OPCs), O4 (pre-oligodendrocytes), and
20,30-cyclic-nucleotide 30-phosphodiesterase (CNPase, pre-oligo-
dendrocytes, and mature oligodendrocytes).67,79,80(Fig. 5C–E).
In 2D, NS/PCs in differentiation medium tended to form
rosette-like clusters positive for OPC markers, similar to previ-
ous reports.81 Cells cultured in 3D, HA hydrogels consistently
showed robust labeling of oligodendrocyte-lineage markers,
which was qualitatively more abundant when compared to
culture in stem cell maintenance medium in 2D or 3D and on
FIGURE 5. Oligodendrocyte-lineage differentiation increases when NS/PC are cultured in 3D under differentiation conditions. (A) OLIG2 mRNA was
evaluated with RT-PCR in NS/PCs cultured in 2D and 3D with various peptides exposed to different media conditions: stem cell maintenance
(STEM), oligodendrocyte-lineage conditioning (PRE-DIFF), and oligodendrocyte differentiation (DIFF). NS/PCs grown in 3D HA with PREDIFF (day 42)
and with full differentiation conditions (PREDIFF, days 28–42 + DIFF, days 43–70) showed a statistically signiﬁcant increase in OLIG2 expression
compared to 2D NS/PCs treated with the same media (*). Error bars show the standard deviation (N ≥ 4). (B) NS/PCs cultured in either 2D (top) or
3D with YIGSR, IKVAV, and RGD peptides (bottom) were immunoﬂuorescently labeled for OLIG2 expression (red). Fewer NS/PCs expressed OLIG2
in 2D, compared to 3D, when cultured in STEM for 42 days. In 2D, OLIG2 expression OLIG2 increased when cultured in differentiation conditions
(day 70) compared to STEM medium (42 days). (C–E) NS/PCs showed an increase in expression of the OPC marker PDGFRα (C), pre-oligodendrocyte
marker O4 (D), and oligodendrocyte marker CNPase (E) when cultured in 3D, HA hydrogels with YIGSR, IKVAV, and RGD peptides (bottom) com-
pared to NS/PCs cultured in 2D (top) in both STEM and DIFF media conditions. Images are 200×; inset images are 1000×.
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laminin-coated, 2D substrates coverslips in any medium. How-
ever, no immunolabeling of myelin basic protein (MBP) was
observed, indicated that oligodendrocyte-lineage cells did not
produce myelin (data not shown).
Astrocyte-lineage differentiation. Glial ﬁbrillary acidic pro-
tein is an intermediate ﬁlament protein whose expression is
associated with activated astrocytes. GFAP is upregulated in
response to inﬂammation and in the glial scar that forms to iso-
late injured tissue from surrounding healthy tissue in the
CNS.21,82,83 Levels of GFAP mRNA were signiﬁcantly decreased
in NS/PCs cultured in 3D, compared to 2D, in pre-differentiation
and differentiation media conditions (Fig. 6A). In 2D cultures,
immunoﬂuorescent staining conﬁrmed a substantial increase in
GFAP levels in differentiation medium, compared to minimal
expression in stem cell maintenance medium. In 3D cultures,
NS/PCS in all conditions had no detectable GFAP (Fig. 6B).
While GFAP expression indicates activated astrocytes, it
is possible that NS/PCs in 3D culture differentiated toward
non-activated astrocytes. Thus, we assessed levels of S100β,
a marker of astroglial differentiation that is not speciﬁc to
activated or reactive astrocytes (Supplementary Fig. 3).21,82,84
While immunoﬂuorescence staining revealed the presence
of a few S100β+ cells in both 2D and 3D cells in all condi-
tions, overall low levels of S100β mRNA expression, which is
often present even on ﬁbrous astrocytes derived from olig2+
progenitors,58 in 3D culture provides evidence that the
OLIG2+ cells observed at days 42 and 70 in 3D, differentia-
tion culture are likely OPCs (Fig. 5A, B). NS/PC culture in HA
hydrogels with CYS peptides in stem cell maintenance
medium at day 28 was the only condition with a statistically
signiﬁcant difference in S100β mRNA levels compared to 2D
cultures at the same time point.
Neuron-lineage differentiation. Next, we evaluated expres-
sion of βIII-tubulin (TUBB3) and doublecortin (DCX), which
both indicate a neuronal or neuronal precursor phenotype
(Fig. 7).21,85 A decrease in TUBB3 mRNA was observed for
2D-cultured NS/PCs in maintenance medium at day 28 com-
pared to those in pre-differentiation medium at day
42 (Fig. 7A). No other statistically signiﬁcant differences in
levels of TUBB3 mRNA were observed. Immunoﬂuorescence
staining for βIII-tubulin protein showed no obvious differ-
ences in expression, in agreement with mRNA results
(Fig. 7B). Immunoﬂuorescence staining for DCX indicated the
presence of more DCX+ cells in 3D culture and an additional
increase when cultured in differentiation medium (Fig. 7B).
To assess differentiation into more mature neurons, we
evaluated expression of neuroﬁlament 200 (NF200), nuclear
antigen (NeuN), and synaptophysin (SYN). Presence of
NF200, an intermediate ﬁlament protein associated with
mature axons, increased with both 3D culture and differenti-
ation medium at day 7086 (Fig. 7C). NeuN is a transcription
factor active in the nucleus of many mature neurons. Nuclear
NeuN was observed only in 3D cultures in differentiation
medium, indicative of active transcriptional regulation of
genes associated with mature neurons86 (Fig. 7D). SYN is a
protein found in pre-synaptic vesicles associated with early
stages of synapse maturation.87 In 2D cultures, SYN was only
present when cultured in differentiation medium at day
70 (Fig. 7E). In 3D cultures, SYN was present in all condi-
tions and increased with differentiation medium at day
70, suggesting that 3D HA hydrogels are conducive to matu-
ration of functional neurons. However, markers for more
speciﬁc mature neuronal subtypes, including serotonin, tyro-
sine hydroxylase, and choline acetyltransferase, were not
present (data not shown).
Electrophysiology
Previous reports have demonstrated that the ECM provided
to NS/PCs in culture can alter their electrophysiological char-
acteristics.88,89 Thus, we performed electrophysiology on
FIGURE 6. GFAP expression by NS/PCs increases with 2D culture and differentiation conditions. (A) GFAP mRNA was evaluated with RT-PCR in 2D
and 3D hydrogels. In 2D, both PREDIFF (day 42) and full differentiation (PREDIFF, days 28–42 + DIFF, days 43–70) conditions signiﬁcantly increased
GFAP expression compared to 2D STEMRPO (day 28) (#). Both PREDIFF (day 42) and differentiation (day 70) conditions in 3D cultures showed a statis-
tically signiﬁcant decrease in GFAP expression compared to NS/PCs cultured in the same media conditions in 2D (*). Error bars show the standard
deviation of multiple experiments. Error bars show the standard deviation (N ≥ 4). (B) NS/PCs cultured in either 2D (top) or 3D with YIGSR, IKVAV, and
RGD peptides (bottom) were immunoﬂuorescently labeled for GFAP (red), a marker of activated astrocytes. Images are 200×; inset images are 1000×.
Media conditions: stem cell maintenance (STEM), oligodendrocyte-lineage conditioning (PRE-DIFF), and oligodendrocyte differentiation (DIFF).
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NS/PCs cultured in 3D HA hydrogels with YIGSR+IKVAV+RGD
for the full 70-day differentiation period (Fig. 8). Recorded
NS/PCs had membrane channels that conducted potassium
and sodium, but were too immature to determine an electro-
physiological phenotype associated with any mature neuronal
subtype. Measured values for capacitance, input resistance,
and resting membrane potential were similar to values mea-
sured in embryonic stem cells89 and induced pluripotent stem
cells90 undergoing neuronal differentiation but not yet fully
matured. While this data is insufﬁcient to deﬁnitively charac-
terize the differentiation of NS/PCs, the observed electrophys-
iological characteristics suggest that NS/PCs were in an
intermediate stage of maturation.
DISCUSSION
Hydrogel biomaterials have immense potential to enable suc-
cessful stem cell-based therapies for CNS regeneration. This
study investigated whether 3D culture in an HA-rich
environment incorporating laminin-derived, adhesive pep-
tides could direct NS/PC differentiation more efﬁciently and
in a more controlled manner than is currently possible with
2D cultures. Results demonstrated that HA-based hydrogels
support viable, 3D cultures of human NS/PCs for at least
70 days and that culture conditions can be used to promote
NS/PC expansion or differentiation, as desired. In addition,
culture in 3D, HA hydrogels increased differentiation toward
both neurons and oligodendrocytes. Very few, if any, astro-
cytes expressing S100β or GFAP were present in 3D cultures.
In contrast, both astrocyte markers were widely observed in
2D culture. As GFAP expression is typically associated with
inﬂammatory astrocytes in vivo, this result agrees with pre-
vious reports that HA hydrogels can reduce the presence of
GFAP+ astrocytes in the spinal cord after injury.52,91
The ECM acts through integrins to regulate NS/PC phe-
notype, including maintenance of a stem-like phenotype and
differentiation toward speciﬁc mature cell types.92,93 Pink-
staff and colleagues identiﬁed a speciﬁc set of integrins are
FIGURE 7. 3D culture increased neuronal differentiation of NS/PCs. (A) βIII-tubulin (TUBB3) mRNA was evaluated with RT-PCR in 2D and 3D HA with
varying adhesive peptides. In STEM (day 42), all 3D conditions showed a statistically signiﬁcant decrease in TUBB3 compared to 2D NSPC at day
28 in STEM (*). Error bars show the standard deviation (N ≥ 4). (B–E) NS/PCs cultured in either 2D (top) or 3D with YIGSR, IKVAV, and RGD peptides
(bottom) were immunoﬂuorescently labeled for neuronal markers. Neuronal differentiation of NS/PCs in 3D cultures increases under
oligodendrocyte-promoting differentiation conditions. (B) Expression of TUBB3 (red) and doublecortin (DCX, green) were observed in all conditions.
DCX expression appeared to increase after undergoing the full, 70-day differentiation protocol (PREDIFF, days 28–42 + DIFF, days 43–70) and in 3D
cultures. For 3D cultures, maximum projections of stacked images acquired using confocal microscopy are shown. (C–E) NS/PCs showed an
increase in expression of mature neuronal markers neuraﬁlament 200 (NF200, C), NeuN (D) synaptophysin (SYN, E) after undergoing the full,
70-day differentiation protocol. NS/PCs grown in 3D hydrogels with YIGSR, IKVAV, and RGD peptides (bottom) showed increased NF200 compared
to those cultured in 2D in both STEM (day 42) and DIFF (day 70) conditions. (D) NS/PCs grown in 3D in DIFF conditions (day 70) exhibited more cells
with nuclear NeuN than 3D cultures in STEM (day 42) or 2D cultures. (E) In 2D, SYN expression increased between STEM (day 42) and DIFF (day
70). In 3D cultures, SYN was observed in both STEM (day 42) and DIFF (day 70) conditions. Images are 200×; inset images are 1000×. Media condi-
tions: stem cell maintenance (STEM), oligodendrocyte-lineage conditioning (PRE-DIFF), and oligodendrocyte differentiation (DIFF).
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expressed in the rat brain.94 Of these, integrin subunits α1,
α3, α6, αV, and β1 are abundant and are known to interact
with laminin and other ECM proteins bearing the RGD
sequence. Integrin dimers αVβ1 and αVβ5 have been linked to
proliferation of NS/PCs.95 For OPCs, various integrin dimers
with the β1 subunit have been found to promote survival,96
regulate a switch from proliferation to differentiation29 and
mediate myelination by mature oligodendrocytes.97,98 Sev-
eral studies have found that inclusion of IKVAV peptides in
hydrogel-type biomaterials increased neuronal differentia-
tion of transplanted NS/PCs after traumatic brain injury.99
Inclusion of IKVAV has also been reported to reduce astro-
gliosis after injury.100,101 In vitro, IKVAV-bearing hydrogels
are reported to promote differentiation of neurons while
reducing differentiation of astrocytes.102,103 YIGSR has also
been reported to support survival and neurogenesis of trans-
planted NS/PCs104 and has been widely found to promote
neurite extension.105,106 YIGSR and IKVAV are known to syn-
ergistically improve neurite attachment and outgrowth.61,62
Their combination has been reported to maximize neurogen-
esis of NS/PCs cultured in 3D HA hydrogels.44 Collectively,
these results and prior studies conﬁrm that RGD, YIGSR, and
IKVAV are supportive of NS/PC survival and differentiation
into oligodendrocytes and neurons.
Despite progress in our understanding, integrin regulation
of NS/PC differentiation is understudied and has potential to
be a valuable tool for developing and implementing stem cell-
based therapies. While this study demonstrated that RGD pep-
tides likely increases cell proliferation in HA hydrogels, no
other peptides or combinations investigated signiﬁcantly
altered NS/PC maturation compared to non-bioactive cysteine.
However, higher cell viability was observed in 3D hydrogels
including RGD peptide, either exclusively or in combination
with YIGSR and IKVAV, after 70 days in culture. Given that
NS/PCs cultured in hydrogels with IKVAV and/or YIGSR with-
out RGD had equivalent viabilities to those with cysteine,
which served as a negative control as it does not bind integ-
rins, higher viability with RGD may be because of the abilities
of RGD to interact with many different integrins and bind
more strongly to integrins, thereby improving cell adhesion.
The decrease in numbers of viable NS/PCs between days
28 and 42 likely can be attributed to the cells ﬁlling, or over-
growing, hydrogel cultures by the later time point. After day
28, NS/PC spheroids continued to grow but often breached
the edges of the hydrogel and were released into the sur-
rounding medium. These spheroids were not included in anal-
ysis of cell numbers and were rinsed away before viability
and phenotype experiments.
As anticipated, removal of the mitogenic factors bFGF
and EGF from culture medium after day 28 in the PREDIFF
and DIFF media reduced proliferation and initiated differen-
tiation of NS/PCs.107,108 A subset of NS/PCs in a population
are expected to undergo apoptosis in response to the differ-
entiation stimuli,108–110 which helps to explain the reduced
numbers of viable cells in differentiation medium at day 70.
However, many NS/PCs were still viable at day 70. Notably,
apoptotic cells were identiﬁed throughout the 3D culture
volume, indicating that cell death was likely not caused by
inadequate diffusion through the hydrogels.
Although CD44 has been reported widely as a marker for
NS/PCs,41,111,112 immunoﬂuorescence labeling in 3D HA
hydrogels indicated sporadic CD44 presence in only a few
cells in all 2D and 3D conditions. Moreover, there was a trend
toward less CD44 expression in 3D compared to 2D cultures.
While the implications of this result remain unclear, it is pos-
sible that the increased HA binding of CD44 may lead to
reduced CD44 expression. Given that CD44 is associated with
stemness41 and our data showing that NS/PCs cultured in 3D,
FIGURE 8. NS/PCs differentiated in 3D HA hydrogels exhibit electrophysiological properties of immature neurons. (A) Infrared differential interfer-
ence contrast microscopy (IR-DIC) image taken from a recorded cell (arrow). Scale bar = 20 μm. (B) Membrane properties of recorded NS/PCs
(N = 5). (C) Whole-cell patch clamp recording at a holding potential of −70 mV shows the presence of occasional synaptic inputs (see arrows) in a
recorded NS/PC. (D) Sample recording from an NS/PC at different voltage steps (−80 mV to +10 mV, 10 mV increments) shows the presence of tran-
sient voltage-gated Na+ inward currents K+ outward currents. (E) Recording of voltage-gated currents from the same NS/PC as shown in D that are
activated during a slowly depolarizing ramp (8 s).
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HA-based hydrogels are more mature than those in 2D, differ-
entiation in 3D cultures may lead to reductions in CD44
expression.41 Another study reported that during differentia-
tion, CD44 remains high in astrocyte progenitors, but is sub-
stantially reduced in OPCs.112 CD44 expression is also seen in
developing and mature, branched ﬁbrous astrocytes.112 In this
study, we observed no astrocyte-lineage differentiation, but
signiﬁcant oligodendrocyte-lineage differentiation. Thus, the
reduction in CD44 expression in 3D cultures may correlate
with an increased oligodendrocyte-lineage differentiation.
However, further investigation is warranted in future studies.
Overall, results from this study demonstrate the potential
utility of HA-based hydrogels for biomanufacturing of stem
cell-based therapies for CNS regeneration. First, NS/PCs
could be expanded for 42 days when cultured in hydrogels
in the presence of mitogens. 3D cultures provide a larger
space for culture expansion than 2D cultures. Thus, more
new cells are generated without the need for passaging,
which may lead to signiﬁcant phenotypic drift affecting ther-
apeutic potential. Furthermore, as relatively high numbers of
NS/PCs are required for clinical use, a 3D culture method for
cell expansion could address this signiﬁcant challenge to
translation. HA hydrogels maintained high levels of SOX2
mRNA and immunostaining consistent with observations
that high expression of SOX2 is conserved throughout
embryogenesis in vertebrate NS/PCs.113
Second, with mitogen withdrawal and progressive addi-
tion of soluble factors intended to promote oligodendrocyte-
lineage differentiation, 3D culture in HA-based hydrogels gen-
erally increased differentiation toward OPCs over monolayer
culture on CELLstart™, evidenced by increased olig2 expres-
sion and nuclear localization coinciding with an increase in
expression of PDGFR-α and followed by increased expression
of O4 and CNPase, early markers of differentiating oligoden-
drocytes. The goal of this study was to establish a baseline for
how these 3D scaffolds affect differentiation. Thus, minimal
soluble growth factor support was provided. However, there
have been several reports detailing how progression addition
of soluble factor cocktails can drive oligodendrocyte differen-
tiation.20,21,27 In future work, we expect that combining 3D
scaffolds with these soluble factor protocols will likely
increase numbers of oligodendrocytes generated.
While many NS/PCs in 3D culture progressed down the
oligodendrocyte lineage, others expressed the neuronal lineage
markers βIII-tubulin and DCX. After 70 days, many cells in dif-
ferentiation medium exhibited signs of more mature neurons,
including nuclear NeuN and synaptophysin expression. How-
ever, electrophysiological measurements and immunostaining
for markers of mature synapses showed that these cells did
not differentiate completely. As the differentiation protocol
used here was designed to promote differentiation into oligo-
dendrocytes, and not neurons, use of a neuron-promoting pro-
tocol may further synaptic maturation in 3D cultures.
Notably, NS/PC differentiation into astrocytes (assessed via
GFAP or S100β expression) was only observed in 2D and not
in 3D cultures. As GFAP expression is associated astrocyte acti-
vation, NS/PC culture on substrates with non-physiological
stiffness, like glass, may promote an inﬂammatory response
from differentiating astrocytes.114–116 High molecular weight
HA, as used here for hydrogel fabrication, has also been shown
to reduce astrocyte proliferation and activation, both of which
may contribute to inhibition of axon regeneration by the glial
scar after injury.91,117
Schwann cells also express S100β and can promote
regeneration of damaged CNS tissue.118,119 Schwann cells
normally myelinate peripheral nerve axons, but have been
observed to remyelinate CNS axons after injury. However,
Schwann cell myelination reduces axon density to a pattern
more similar to peripheral nerves than CNS, limiting the
overall effectiveness of Schwann cells in CNS repair.119,120
As NS/PCs are unlikely to differentiate into Schwann cells
due to differences in their developmental origins,118,121 it is
likely S100β+ cells in these studies, even those not expres-
sing GFAP, were astroglial cells.
Hyaluronic acid hydrogel stiffness and degradability are
areas of particular importance for future studies. Hydrogel
stiffness affects differentiation of cultured NS/PCs, with peak
differentiation toward neurons when stiffness is closest to
that of normal brain tissue.122 Previous work found that
NS/PCs respond to stiffness in a time-dependent manner,
typically on a time scale of seconds to minutes.123 This ﬁnd-
ing suggests that NS/PCs may “remember” a previous
mechanical stimulus that primes them toward a particular
lineage. Thus, it is possible that stiffness of a culture material
could be transiently altered to create an environment select-
ing for differentiation to a speciﬁc phenotypic fate.
In general, HA found in the normal CNS tissues is high
molecular weight (>500 kDa), where it is more thought to
help maintain NS/PC stemness124,125 and quiescence.39,126
However, low molecular weight HA (<30 kDa) may promote
differentiation,127 while mid-sized HA (~65 kDa) has been
reported to inhibit OPC maturation and myelination.128 Thus,
the presence of high molecular weight HA (~700 kDa) in the
3D cultures may prevent complete maturation. While HA
may be a beneﬁcial material to initiate NS/PC proliferation
and early OPC differentiation, it may also create an inhibi-
tory “valley” that prevents full maturation. In the future, it
will be beneﬁcial to evaluate effects of lower molecular
weight HA in hydrogel cultures, either by using smaller HA
to form hydrogels or by digesting larger HA molecules with
hyaluronidase after cell encapsulation. In future studies,
incorporating additional regions that can be enzymatically
degraded by cells cultured 3D hydrogels may provide an
extra parameter to direct NS/PC fate.129
Hyaluronic acid hydrogels are a useful scaffolding mate-
rial for 3D culture of NS/PCs and as bioactive carriers of
therapeutic cells for CNS regeneration. HA hydrogels have
beneﬁcial effects on recovery after brain or spinal cord
injury in rodents as they decrease inﬂammation52,101 and
improve NS/PC cell survival following transplantion.130,131
The tunable hydrogel platforms reported here can be used
to characterize how stiffness, peptide concentration, ECM
content, degradability, and soluble factors interact to dynam-
ically coordinate NS/PC differentiation into speciﬁc fates,
helping to inform the optimal design of regenerative scaf-
folds. As the hydrogel chemistry used in this study is
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compatible with injection and gelation in situ, which is an
advantage to avoid excessive tissue damage when delivered
to the CNS, the same scaffolds found to direct NS/PC fate
in vitro can be easily translated in vivo to evaluate their ther-
apeutic effects.
CONCLUSIONS
This study demonstrates that 3D culture in HA-based hydro-
gels can be used to expand or differentiate human NS/PCs
with improved efﬁciency over standard 2D cultures. Inclu-
sion of the RGD adhesive peptide increased cell viability in
the early growth phase and through the 70-day differentia-
tion period. Differentiation toward neurons and oligodendro-
cytes was increased signiﬁcantly in 3D over 2D cultures,
while differentiation into reactive astrocytes was reduced.
However, differentiation into fully mature oligodendrocytes
or neurons was not observed. The laminin I-derived adhe-
sive peptides included had no signiﬁcant effects on NS/PC
fate. Taken together, these results establish that 3D, HA-
based culture platforms can improve viability, expansion and
differentiation of human NS/PCs and underscore the exciting
potential of 3D, HA-based culture system for biomanufactur-
ing of therapeutic NS/PCs.
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